Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1A | P08908 | 10/20 | 0.42 |
| ▸ | HTR7 | P34969 | 10/20 | 0.42 |
| ▸ | DRD2 | P14416 | 5/20 | 0.42 |
| ▸ | HTR6 | P50406 | 5/20 | 0.42 |
| ▸ | SFRP1 | Q8N474 | 8/20 | 0.41 |
| ▸ | WNT3 | P56703 | 3/20 | 0.41 |
| ▸ | HTR2A | P28223 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.38 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.38 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4617920 | 0.92 | HTR1A (0.45) | HTR1AHTR7DRD2HTR6SFRP1 | |
| SCHEMBL4616210 | 0.90 | KDM4E (0.46) | HTR1AHTR7DRD2HTR6SFRP1 | |
| SCHEMBL4617601 | 0.90 | HTR1A (0.44) | HTR1AHTR7DRD2HTR6SFRP1 | |
| SCHEMBL4617737 | 0.89 | ALDH1A1 (0.46) | HTR1AHTR7DRD2HTR6SFRP1 | |
| SCHEMBL6103313 | 0.87 | HTR1A (0.42) | HTR1AHTR7DRD2HTR6SFRP1 | |
| SCHEMBL4617906 | 0.87 | SFRP1 (0.56) | HTR1AHTR7DRD2HTR6SFRP1 | |
| SCHEMBL4615580 | 0.86 | IKBKB (0.42) | HTR1AHTR7DRD2HTR6SFRP1 | |
| SCHEMBL4618933 | 0.86 | HTR1A (0.41) | HTR1AHTR7DRD2HTR6SFRP1 | |
| SCHEMBL4617898 | 0.85 | HTR1A (0.36) | HTR1AHTR7DRD2HTR6SFRP1 | |
| SCHEMBL6102396 | 0.82 | SFRP1 (0.51) | SFRP1WNT3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1879859-A2 | DIARYLSULFONE SULFONAMIDES AND USE THEROF | Wyeth a Corporation of the State of Delaware (US) | 2008-01-23 | — | — | EP | claimed |
| US-20060276464-A1 | Diarylsulfone sulfonamides and use thereof | WYETH (US) | 2006-12-07 | — | — | US | claimed |
| WO-2006124875-A2 | DIARYLSULFONE SULFONAMIDES AND USE THEROF | WYETH (US) | 2006-11-23 | — | — | WO | claimed |
| EP-1879859-A2 | DIARYLSULFONE SULFONAMIDES AND USE THEROF | Wyeth a Corporation of the State of Delaware (US) | 2008-01-23 | — | — | EP | disclosed |
| US-20060276464-A1 | Diarylsulfone sulfonamides and use thereof | WYETH (US) | 2006-12-07 | — | — | US | disclosed |
| WO-2006124875-A2 | DIARYLSULFONE SULFONAMIDES AND USE THEROF | WYETH (US) | 2006-11-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060276464-A1 | Diarylsulfone sulfonamides and use thereof | SFRP1, SOS1, FZD7 | HTR1A 3561/4885HTR7 3430/4885DRD2 4401/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.